Early Clinical Development of a Live, Attenuated Combination Vaccine Against Shigella and ETEC Diarrhoea: Phase 1b Clinical Trial of ShigETEC Vaccine in Bangladeshi Adults and Three Paediatric Age Groups is a PHASE1 clinical asset sponsored by Eveliqure Biotechnologies GmbH in Healthy Volunteers. SEO and diligence focus: ShigETEC live, attenuated, oral vaccine, Placebo, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.